Postnatal development of organic cation transport and mdr gene expression in mouse kidney.
The apical surface of the proximal tubular epithelium is the site of both P-glycoprotein localization and postulated active secretion of organic cations in the mammalian kidney. P-glycoprotein has been shown to act as a pleiotropic drug efflux pump across the cell membrane of tumor cells expressing the multidrug resistance phenotype, whereas the renal organic anion and organic cation secretory systems serve the function of pleiotropic drug transport across the proximal tubule epithelium. Because most known substrates for P-glycoprotein are organic cations, we tested the hypothesis that the physiological function of this protein in the kidney is to mediate renal organic cation secretion. In one approach, we compared the postnatal development of organic cation transport with that of kidney mdr gene expression. Cimetidine-sensitive uptake of classical substrates for renal secretion (N-methyl nicotinamide and tetraethylammonium) into kidney slices developed gradually in neonate mice, reaching adult capacity in 4 to 6 weeks. P-glycoprotein and its mRNA, as estimated by immunohistochemical methods and RNAse protection analysis, were undetectable at birth and were expressed abruptly at the adult level between 2 and 3 weeks of age. In another approach, classical inhibitors of renal organic cation secretion (cimetidine and cyanine 863) failed to reverse resistance to adriamycin in Chinese hamster ovary and P388 cell lines, which possess the phenotypic traits of multidrug resistance. These results suggest that the cimetidine-sensitive component of organic cation secretion is mediated by a protein other than the P-glycoprotein in the mammalian kidney.
Department of Experimental Pediatrics, University of Texas M. D. Anderson Cancer Center, Houston.
A
A
Dutt
T S
TS
Priebe
L D
LD
Teeter
M T
MT
Kuo
J A
JA
Nelson
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000818:Animals; D000831:Animals, Newborn / Q000235:genetics / Q000254:growth & development*; D001692:Biological Transport / Q000235:genetics; D002927:Cimetidine / Q000494:pharmacology; D046508:Culture Techniques; D015870:Gene Expression; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D008099:Liver / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000032:analysis / Q000502:physiology*; D051379:Mice; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000378:metabolism; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000378:metabolism*
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D008562:Membrane Glycoproteins; D013757:Tetraethylammonium Compounds; D009536:Niacinamide; D019789:Tetraethylammonium; D002927:Cimetidine; C008472:N-methylnicotinamide